MIR4513 Gene

HGNC Family Non-coding RNAs
Name microRNA 4513
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have revealed that miR‑4513 broadly impacts cardiometabolic regulation. A common single nucleotide polymorphism (rs2168518) within its seed region has been robustly associated with altered fasting glucose, cholesterol levels, blood pressure, and coronary artery disease risk, suggesting that miR‑4513 modulates key metabolic pathways underlying cardiovascular homeostasis and disease susceptibility."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn oncological contexts, miR‑4513 has emerged as a significant player in tumor progression and therapy response. In lung adenocarcinoma, the rs2168518 variant contributes to differential sensitivity to epidermal growth factor receptor–tyrosine kinase inhibitors, with functional experiments demonstrating that miR‑4513 can enhance resistance to gefitinib. Meanwhile, in gastric and breast cancers, elevated expression of miR‑4513 promotes cell proliferation, invasion, and epithelial–mesenchymal transition by targeting critical regulators such as lysine acetyltransferase 6B, and by participating in regulatory axes (for example, the MEG3/miR‑4513/PBLD network) that modulate chemoresistance to paclitaxel. Together, these findings underscore the multifaceted role of miR‑4513 in cancer biology and its potential as a prognostic biomarker and therapeutic target."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "6"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the mechanistic level, allele‐specific investigations have demonstrated that the rs2168518 polymorphism in miR‑4513 leads to differential regulation of a distinct set of target genes. Transcriptomic and functional analyses have identified numerous allele‐dependent targets whose altered regulation may underlie the microRNA’s diverse effects—including modulation of transcription factor binding sites that could account for tissue- and gender-specific phenotypes, such as those observed in age-related macular degeneration. These mechanistic insights further corroborate the notion that miR‑4513 functions as a pleiotropic regulator, fine-tuning gene expression networks involved in both cardiometabolic processes and oncogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Mohsen Ghanbari, Paul S de Vries, Hans de Looper, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A genetic variant in the seed region of miR-4513 shows pleiotropic effects on lipid and glucose homeostasis, blood pressure, and coronary artery disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.22706"}], "href": "https://doi.org/10.1002/humu.22706"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25256095"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25256095"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Rashid Mir, Chandan K Jha, Imadeldin Elfaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Incidence of MicroR-4513C/T Gene Variability in Coronary Artery Disease - A Case-Control Study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr Metab Immune Disord Drug Targets (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/1871530319666190417111940"}], "href": "https://doi.org/10.2174/1871530319666190417111940"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31038082"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31038082"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Heba Mohamed Ali, Doha El-Sayed Ellakwa, Nesma Mohamed Elaraby, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Study the association of microRNA polymorphisms (miR-146a, miR-4513) with the risk of coronary heart diseases in Egyptian population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem Mol Toxicol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jbt.23284"}], "href": "https://doi.org/10.1002/jbt.23284"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36541377"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36541377"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Nasha Zhang, Yankang Li, Yan Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lab Invest (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41374-018-0164-y"}], "href": "https://doi.org/10.1038/s41374-018-0164-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30552364"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30552364"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Huimin Ding, Yuhua Shi, Xiaobing Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-4513 Promotes Gastric Cancer Cell Proliferation and Epithelial-Mesenchymal Transition Through Targeting KAT6B."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Gene Ther Clin Dev (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/humc.2019.094"}], "href": "https://doi.org/10.1089/humc.2019.094"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31310159"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31310159"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Mingzhi Zhu, Fang Wang, Hailong Mi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2020.1839700"}], "href": "https://doi.org/10.1080/15384101.2020.1839700"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33121324"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33121324"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Christina Kiel, Tobias Strunz, International Amd Genomics Consortium Project Manager Susan Blanton Iamdgc, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pleiotropic Locus 15q24.1 Reveals a Gender-Specific Association with Neovascular but Not Atrophic Age-Related Macular Degeneration (AMD)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cells (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/cells9102257"}], "href": "https://doi.org/10.3390/cells9102257"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33050031"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33050031"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Christina Kiel, Tobias Strunz, Daniele Hasler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Seed sequence polymorphism rs2168518 and allele-specific target gene regulation of hsa-miR-4513."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddab292"}], "href": "https://doi.org/10.1093/hmg/ddab292"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34605899"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34605899"}]}]}]}
NCBI Gene ID 100616183
API
Download Associations
Predicted Functions View MIR4513's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR4513's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR4513's ARCHS4 Predicted Functions.

Functional Associations

MIR4513 has 905 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 11 datasets.

Click the + buttons to view associations for MIR4513 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4513 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR4513 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR4513 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4513 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR4513 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR4513 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR4513 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of MIR4513 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4513 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR4513 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR4513 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.